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Abstract
Background: Increased expression of the pro-fibrotic protein connective tissue growth factor (CTGF) has been
detected in injured kidneys and elevated urinary levels of CTGF are discussed as prognostic marker of chronic
kidney disease. There is evidence that epithelial cells lining the renal tubular system contribute to uptake and
secretion of CTGF. However, the role of different types of tubular epithelial cells in these processes so far has not
been addressed in primary cultures of human cells.
Results: Tubular epithelial cells of proximal and distal origin were isolated from human kidneys and cultured as
polarized cells in insert wells. The pro-fibrotic stimuli lysophosphatidic acid (LPA) and transforming growth factor β
(TGF-β) were used to induce CTGF secretion.
LPA activated CTGF secretion in proximal tubular cells when applied from either the apical or the basolateral side as
shown by immunocytochemistry. CTGF was secreted exclusively to the apical side. Signaling pathways activated by
LPA included MAP kinase and Rho kinase signaling. TGF-β applied from either side also stimulated CTGF secretion
primarily to the apical side with little basolateral release.
Interestingly, TGF-β activation induced different signaling pathways depending on the side of TGF-β application.
Smad signaling was almost exclusively activated from the basolateral side most prominently in cells of distal origin.
Only part of these cells also synthesized CTGF indicating that Smad activation alone was not sufficient for CTGF
induction. MAP kinases were involved in apical TGF-β-mediated activation of CTGF synthesis in proximal cells and a
subset of epithelial cells of distal origin. This subpopulation of distal tubular cells was also able to internalize
recombinant apical CTGF, in addition to proximal cells which were the main cells to take up exogenous CTGF.
Conclusions: Analysis of polarized human primary renal epithelial cells in a transwell system shows that vectorial
secretion of the pro-fibrotic protein CTGF depends on the cell type, the stimulus and the signaling pathway
activated. In all conditions, CTGF was secreted mainly to the apical side upon TGF-β and LPA treatment and
therefore, likely contributes to increased urinary CTGF levels in vivo. Moreover, CTGF secreted basolaterally may be
active as paracrine pro-fibrotic mediator.
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Background
Connective tissue growth factor (CTGF, CCN2) is a
secreted matricellular protein which has been associated
with fibrotic diseases, often mediating the pro-fibrotic
effects of transforming growth factor β (TGF-β) [1,2].
Elevated levels of CTGF have been described in condi-
tions of tissue injury and inflammation, in different ani-
mal models of kidney injury and also in human biopsy
specimens [3-5]. In the rat model of unilateral ureter ob-
struction (UUO) CTGF protein was increased promin-
ently in tubular epithelial cells [6]. An increased number
of cells expressing CTGF mRNA was observed in human
biopsies specimens at sites of chronic tubulointerstitial
damage, the majority of which co-expressed alpha-
smooth muscle actin [7]. Thus, inflammatory and fi-
brotic situations seem to induce CTGF synthesis in
interstitial as well as in tubular cells.
Urinary CTGF is a marker of chronic kidney disease
such as progressive hypertensive nephrosclerosis [8], dia-
betic nephropathy [9,10] or chronic renal allograft injury
[11,12]. It was assumed that urinary CTGF reflected
increased synthesis of CTGF by glomerular and tubu-
lointerstitial cells. Analysis of human kidney sections
showed CTGF mRNA and protein in severely damaged
human tubules but not in normal epithelial cells [7,13].
However, in a recent study, proximal tubular dysfunction
was identified as major determinant of urinary CTGF ex-
cretion [14]. CTGF was detected in apical endocytic vesi-
cles of proximal tubular cells in mice treated with
recombinant CTGF, suggesting that under normal condi-
tions CTGF is reabsorbed almost completely and thus
not detectable in the urine unless reabsorption is
impaired. Depending on the pathophysiological setting,
tubular epithelial cells may thus be a source or sink for
urinary CTGF.
In vivo, epithelial cells are polarized with structurally
and functionally distinct basolateral and apical domains.
Polarization of epithelial cells in vitro can be achieved by
culturing the cells on transwell membranes where they
have access to nutrients and growth factors from two
sides. MDCK cells derived from distal tubular cells readily
establish dense polarized monolayers characterized by
high transepithelial electrical resistence (TEER), whereas
cell lines obtained from proximal parts of the nephron
show lower TEER in line with the higher capacity for para-
cellular transport of proximal nephron segments [15,16].
Correspondingly, epithelial cells lining the different parts
of the nephron vary in their cell-cell adhesion proteins,
tight junction proteins and cadherins [17]. Proximal tubu-
lar cells are the only epithelial cells in the human adult or-
ganism which express N-cadherin instead of E-cadherin as
major cell-cell adhesion protein, which allows differenti-
ation of cells of proximal and distal origin by immuno-
cytochemistry [18,19]. CTGF secretion from polarized
human tubular cells has not been addressed at all and the
subtype of tubular cells responsible for CTGF secretion
has not been identified. Furthermore, the direction of
CTGF secretion to the apical or basolateral side is un-
known, because thus far, CTGF synthesis has been ana-
lyzed only in non-polarized primary human tubular
epithelial cells and epithelial cell lines [18,20-22].
While TGF-β is the most important pro-fibrotic stimu-
lus, other mediators add to inflammatory and fibrotic
reactions in the kidney as, for example, lysophosphatidic
acid (LPA). LPA is released from platelets upon stimula-
tion but is also produced from phosphatidylcholine by
extracellular phospholipases upon cell damage [23]. By
binding to several G-protein-coupled receptors it acts as
pleiotropic mediator of multiple cellular effects [24]. In
earlier studies, LPA was characterized as a growth and
survival factor of proximal tubular cells [25] and related
to inhibition of apoptosis and complement activation in
reperfusion injury [26]. More recently activation of LPA1
receptors was reported in the UUO model of renal fibro-
sis, which was ameliorated upon LPA1 inhibition [27].
Along this line we have shown earlier that LPA is a po-
tent inducer of CTGF in several cell types, among them
mesangial cells and renal fibroblasts [28,29]. LPA as an
activator of CTGF synthesis has not yet been investigated
in primary tubular epithelial cells.
In this study, we addressed the question whether epi-
thelial cells of proximal or distal tubular origin respond
to the pro-fibrotic stimuli LPA and TGF-β by vectorial
stimulation of CTGF synthesis and secretion. For this
purpose, we used our recently established cell culture
model of primary human tubular cells [18]. We show
marked differences between both stimuli in terms of
activated cells and route of application.
Results
Apical secretion of CTGF upon stimulation with LPA
Primary tubular cells were isolated from healthy parts of
human kidney nephrectomies. Cells obtained from prox-
imal or distal parts of the nephron were distinguished by
the expression of specific cell-cell adhesion molecules,
N-cadherin in proximal and E-cadherin in distal tubular
cells as described earlier [18]. When the cells were cul-
tured for at least 8 days on porous membranes in trans-
well inserts, they developed a polarized structure,
visualized by the apical orientation of cilia above the nu-
clei identified by staining with an antibody against acety-
lated tubulin (Figure 1A). For comparison, non polarized
cells display cilia which do not extend above the cells. In
these cells, part of the tubular network also consisted of
acetylated tubulin (Figure 1A). To show the integrity of
the polarized monolayer, transepithelial electrical resist-
ance (TEER) was determined using a Voltohmeter
(EVOM). Values of 100 to 200 Ω x cm2 were obtained
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after 8 days and increased when the cells became denser
(Figure 1B). As expected, there was variability depending
on the composition of the primary cells, resistance being
higher in distal cells compared to proximal cells.
Figure 1B shows an example of a preparation consisting
primarily of distal tubular cells.
Polarized epithelial cells were stimulated with LPA
(10 μM) from the apical or the basolateral side. Apical
secretion of CTGF was rapidly induced within 2 to 4 h
as shown by Western blotting (Figure 2A), whereas baso-
lateral CTGF secretion was below the detection limit
(Figure 2C). There was no significant difference between
apical and basolateral application of LPA.
By immunocytochemical analysis intracellular CTGF is
only visible when it is newly synthesized and transported
in vesicles from the endoplasmic reticulum through the
golgi [30]. Ongoing CTGF synthesis was detected by both,
basolateral and apical application of LPA. CTGF expres-
sion was almost exclusively in cells of proximal origin,
which lacked E-cadherin expression (Figure 2B). Higher
magnification showed the perinuclear localization of
CTGF (Figure 2C).
Using low molecular weight inhibitors we analyzed
which signaling pathways contributed to LPA-mediated
up-regulation of CTGF expression. Inhibition of p42/44
MAP kinase/ERK1/2 activation by U0106 and to a lesser
degree inhibition of the activity of p38 kinase by
SB203580, reduced LPA-induced secretion of CTGF.
Furthermore, Rho kinases were involved as LPA-
mediated induction of CTGF was prevented by Y27632,
an inhibitor of Rho-kinase signaling (Figure 2D).
Basolateral and apical stimulation by TGF-β induced
apical secretion of CTGF
Secretion of CTGF induced by TGF-β was detectable after
6 and 24 h and was thus slower than upon stimulation
with LPA (Figure 3). There was a marked difference in the
amount of CTGF retrieved from the apical and basolateral
compartments, apical secretion being much higher than
basolateral secretion. TGF-β stimulated apical CTGF se-
cretion when applied to the apical or basolateral side of
the cells, although apical application was more effective
(Figure 3A). Basolateral secretion was very low, irrespect-
ive of TGF-β application from the apical or basolateral
side and was not detectable in all experiments (Figure 3B).
As a matricellular protein CTGF binds to extracellular
matrix proteins but may also attach to plastic. To prevent
loss of CTGF from the supernatants, experiments were
Figure 1 Polarized culture of primary human tubular epithelial cells (hPTEC). A: Freshly isolated hPTEC were cultured for 8 days in transwell
inserts. Cilia were stained with acetylated tubulin and nuclei were visualized by Hoechst. For comparison, non polarized cells are shown in the
right panel. Scale bar: 10 μm. B: hPTECs were cultured for 8 to 13 days in transwell inserts. Transepithelial electrical resistance (TEER) was measured
in three cultures of one preparation. Data are means +/− SD.
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also performed in the presence of heparin, a binding pro-
tein for CTGF. The total amount of CTGF detectable in
the supernatants was increased whereas the proportions
of CTGF secretion were not altered (data not shown). To
further characterize regulation of CTGF expression
mRNA was isolated from cells cultured in inserts and ana-
lyzed by realtime quantitative PCR (Figure 3C). Stimula-
tion with apical or basolateral TGF-β increased CTGF
mRNA levels in line with transcriptional regulation of
CTGF expression.
As TGF-β is a potent inducer of extracellular matrix
proteins, we additionally analyzed fibronectin secretion.
In contrast to CTGF secretion, released fibronectin was
not detectable until 24 h after induction by TGF-β.
Moreover, there was a considerable release of fibronectin
to the basolateral side in all experiments (example shown
in Figure 4). Quantification of fibronectin in the cell cul-
ture supernatant was variable most likely due to the fact
that secreted fibronectin is not entirely soluble but forms
a fibrillar network attached to the cells.
Predominant activation of distal tubular cells by TGF-β
Immunocytochemical analyses were performed to distin-
guish effects of TGF-β on cells of proximal and distal
origin. Activation of Smads is one of the major signaling
pathways of TGF-β and was detected as nuclear trans-
location of Smad2/3 after 1 h incubation. In Figure 5,
Smad2/3 translocation was analyzed and correlated to E-
cadherin double staining identifying cells of distal origin.
In control cells, Smad 2/3 was located in the cytosol.
Treatment with TGF-β from the apical side activated
translocation of Smad 2/3 only in few cells. Part of them
were E-cadherin negative and thus of proximal origin
(arrows in Figure 5). Other responding cells showed
weak E-cadherin staining (arrowheads, Figure 5) which
marked them as distal tubular cells. By contrast, TGF-β
stimulation from the basolateral side quantitatively acti-
vated Smad2/3 translocation in all E-cadherin positive
cells and also some proximal cells (examples indicated
by arrows in Figure 5, lower panel). Location of Smad2/3
in the nucleus of proximal cells was confirmed by co-
staining of N-cadherin (data not shown).
CTGF is a secreted protein and therefore difficult to
detect by immunocytochemistry within cells. In control
cells, CTGF synthesis was often detected in proximal
epithelial cells which formed irregular densely packed
structures (Arrows in Figure 6A, upper panel). Upon
basolateral stimulation with TGF-β CTGF was primarily,
but not exclusively, detected in distal, E-cadherin-posi-
tive, tubular epithelial cells (Figure 6A, lower panel). In
contrast to the general activation of Smad2/3 in distal
tubular cells, induction of CTGF expression was
restricted to individual distal cells as shown by higher
magnification (Arrows in Figure 6B, upper panel). Al-
though only occasionally, we observed CTGF secretion
also in proximal epithelial cells (Arrows in Figure 6B,
lower panel).
Stimulation with TGF-β from the apical side for 1 and
2 h did not lead to accumulation of CTGF in intracellu-
lar vesicular structures, suggesting a rapid release mech-
anism. To interfere with CTGF secretion polarized cells
were treated with brefeldin A which disrupts Golgi struc-
tures and thus inhibits transport of secreted proteins. In
the presence of brefeldin A TGF-β applied to the apical
side of the cells induced CTGF accumulation primarily
in a subset of distal tubular cells expressing low levels of
E-cadherin (Figure 6C, arrow heads), and also in individ-
ual proximal cells (Figure 6C, arrows).
Taken together, basolateral application of TGF-β
induced CTGF synthesis primarily in distal tubular cells
whereas apical application activated proximal cells and a
subset of weakly E-cadherin positive distal cells.
MAP kinases are essential for apical TGF-β -mediated
secretion of CTGF
The poor activation of Smad translocation by apically ap-
plied TGF-β suggested additional non-canonical signal-
ing pathways being involved in CTGF induction. We
pre-incubated hPTEC with the indicated inhibitors and
then stimulated the cells with TGF-β from the apical
side. Inhibition of Rho kinases did not significantly re-
duce CTGF induction, whereas inhibition of ERK1/2 by
UO106 and p38 kinase by SB203580, almost completely
prevented apical TGF-β-mediated induction of CTGF
(See figure on previous page.)
Figure 2 Incubation with apical or basolateral LPA stimulated apical secretion of CTGF. A: Polarized hPTEC were stimulated with LPA
(10 μM) from the basolateral side (L-b) or from the apical side (L-a) for 2 and 4 h. CTGF was detected in the apical compartment. The graph
summarizes data (means +/− SD) of 5 (2 h) and 3 (4 h) independent experiments. Values of secretion of control cells were set to 1 at each time
point. * p < 0.05; ** p < 0.01, Dunnet’s multiple comparison test. B/C: Polarized hPTEC were stimulated with LPA (10 μM) from the apical or
basolateral side for 1 h. CTGF and E-cadherin were visualized by immunocytochemistry. Nuclei were stained with Hoechst. Cells negative for E-
cadherin represent proximal tubular cells. Newly synthesized CTGF was detectable in a perinuclear localization (C; nuclei colored in red; CTGF in
green, scale bar: 10 μm). Arrows indicate examples of CTGF positive proximal cells. Scale bar: 50 μm. D: Polarized hPTEC were pre-incubated with
the inhibitors (U0: U0106, 1 μM; SB203: SB203580 1 μM; Y27: Y27632, 10 μM) for 30 min and then stimulated with LPA (10 μM) from the apical
and basolateral side for 4 h. Secreted CTGF was detected in the apical (a) and basolateral (b) compartment. The graph summarizes data obtained
with two isolations. Apical secretion of LPA-stimulated cells was set to 1 in each experiment.
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secretion (Figure 7A). Furthermore, CTGF induction was
completely prevented, when the TGF-β receptor I (Alk-
5) was inhibited by SB43152 indicating that the cells ex-
press TGF-β receptors also in the apical membrane. To
support a role for ERK1/2 in TGF-β signaling, activation
of ERK1/2 was determined in cellular homogenates of
cells cultured in inserts. As shown by Western blot ana-
lysis, ERK1/2 was phosphorylated when TGF-β was ap-
plied apically (Figure 7B).
Uptake of apical CTGF by proximal tubular epithelial cells
CTGF has been reported to be taken up by mouse prox-
imal tubules in vivo [14]. Therefore, we analyzed uptake
of exogenous CTGF in polarized hPTEC. Polarized cells
were incubated with recombinant human CTGF applied
to the apical or basolateral side. Within 15 minutes, ap-
ical CTGF was detectable in intracellular vesicles. Up-
take was confined to N-cadherin expressing proximal
tubular cells (Overview in Figure 8A, details at higher
magnification Figure 8B). Furthermore, uptake was de-
tectable in a subset of weakly stained E-cadherin positive
cells (Figure 8C), which did not express N-cadherin (data
not shown). Cells with strong E-cadherin positive cell-
cell contacts did not take up exogenous CTGF. No ves-
icular CTGF uptake was detectable when recombinant
CTGF was applied to the basolateral compartment.
Discussion
In this study we show that CTGF is secreted from differ-
ent types of polarized epithelial cells derived from the
human renal tubular system. We provide evidence that
CTGF secretion is specifically regulated depending on
the cell type, the stimulus and the side of application.
Proximal tubular cells were the main target cells of LPA
stimulation and Rho kinase signaling was activated in
these cells. By contrast, TGF-β primarily stimulated dif-
ferent types of distal tubular epithelial cells. Basolateral
TGF-β activated Smad signaling whereas MAP kinases
were essential for apical activation of CTGF secretion by
TGF-β.
Epithelial cells derived from human kidneys are func-
tionally and structurally heterogeneous depending on
their origin along the renal tubular system. This is also
reflected in terms of epithelial barrier function and, at
the cellular level, tight junctions. Renal proximal tubules
are characterized as ‘leaky’ nephron segments with para-
cellular transport of NaCl, which may in part relate to
the expression of claudin-2 [31,32]. Claudin-2 has also
been shown to be involved in transepithelial resistance
determined in different types of MDCK cells [33]. Pri-
mary cells obtained from healthy sections of human
tumor nephrectomies differ in their composition as cells
are obtained from various parts of the nephron. This was
reflected in our measurements of transcellular resistance
of the polarized cells which varied depending on the cel-
lular composition. Preparations which consisted almost
exclusively of cells of distal origin showed higher resist-
ance than preparations which contained a higher propor-
tion of proximal cells.
By immunocytochemistry, human cells of proximal
and distal origin can be distinguished by their expression
of different cell-cell adhesion proteins [18]. Morpho-
logically, E-cadherin positive cells could be further subdi-
vided in cobble-stone like cells which showed a strong
E-cadherin immunoreactivity, and more elongated cells
with less intense staining for E-cadherin. Studies are on-
going to further characterize the origin of these cells, be-
cause they markedly differed in their response to TGF-β
as outlined in detail below. Proximal tubular cells
uniquely express the mesenchymal cell-cell adhesion
molecule N-cadherin. These cells appeared to be less
polarized than distal cells, and their adherence to mem-
branes is less tight. In the coculture system of primary
cells proximal cells were surrounded by distal cells and
thus exposed to mechanical stress. Proximal cells tended
(See figure on previous page.)
Figure 3 Secretion of CTGF from polarized hPTEC stimulated with TGF-β. Polarized hPTEC were stimulated with TGF-β for 6 and 24 h from
the basolateral side (T-b) or from the apical side (T-a). CTGF was detected in the apical (A) or basolateral (B) compartment. The blots shown are
from a representative experiment performed with duplicate inserts. The graphs summarize means +/− SD of 6 (A) and 3 (B) experiments with
different hPTEC isolations. Expression of control cells in each experiment was set to 1. * p < 0.05, ** p < 0.01, Dunnet’s multiple comparison test. C:
RNA was isolated from polarized cells treated with TGF-β for 3 h. CTGF mRNA expression was determined by real time quantitative RT-PCR and
corrected for 18 S RNA. Data are means +/− SD of duplicate determinations of duplicate inserts. RNA in control cells was set to 1. * p < 0.05, **
p < 0.01, Dunnet’s multiple comparison test.
Figure 4 Secretion of fibronectin. Polarized hPTEC were
stimulated with TGF-β from the basolateral and from the apical side
for 24 to 72 h. Secreted CTGF and fibronectin were detected in the
basolateral (b) or apical (a) compartment. The blot is representative
of 3 experiments with different hPTEC isolations. In the experiment
shown CTGF was below the detection limit in the basolateral
compartment.
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to form multilayered structures, which often stained
positive for CTGF in line with the known sensitivity of
CTGF expression to mechanical stimulation [34,35].
Proximal tubular cells thus seem to be more suscep-
tible to stimuli which modulate the actin cytoskeleton,
be it by mechanical stress or by stimuli such as LPA,
which activates Rho-Rho kinase signaling and modulates
actin stress fibers [24]. We have shown earlier that in-
duction of CTGF is sensitive to Rho-Rho kinase signaling
in mesenchymal cells and that alterations in the actin
cytoskeleton may induce CTGF expression by modulat-
ing G-actin and MAL/SRF dependent transcription in
renal fibroblasts and endothelial cells, respectively
[28,36,37]. By contrast, regulation of MAL/SRF-mediated
gene regulation was mediated by Rac1 signaling rather
than Rho-Rho kinase signaling in MDCK cells activated
by calcium deprivation [38]. In polarized hPTEC, inhib-
ition of Rho kinase signaling affected LPA-induced
CTGF up-regulation but not TGF-β-mediated induction.
This may be due to different signaling pathways activated
by both stimuli and by the cell types activated. LPA acti-
vated almost exclusively N-cadherin positive proximal
tubular cells.
Secretion of CTGF was clearly favored to the apical
side of the cells. Thus far, rather little is known about
the molecular mechanisms regulating CTGF secretion.
Comparison of CTGF secretion with the secretion of
fibronectin indicated that the apical secretion of CTGF
was a regulated vectorial process which differed from the
secretion of fibronectin, the basolateral secretion of
which was much more pronounced. Other secreted pro-
teins such as e.g. metalloproteinases were detected com-
parably in the apical and basolateral compartment of the
transwell cultures (data not shown) further endorsing
the specificity of CTGF secretion.
Based on the data obtained with LPA, it was clear
that proximal tubular epithelial cells secreted CTGF to
the apical side. However, as long as the molecular
mechanisms of CTGF secretion have not been deci-
phered, we cannot rule out that other stimuli may acti-
vate also basolateral secretion of CTGF from proximal
tubular cells.
LPA stimulated CTGF expression applied from both
sides. In line with these data CTGF receptors have been
characterized in both, apical and basolateral membranes
of polarized gastrointestinal Caco-2 cells [39]. By con-
trast, TGF-β was reported to activate Caco-2 cells and
MDCK cells only when applied to the basolateral side
[40-42]. However, localization of TGF-β receptors seems
to vary between different epithelia. Even with certain
MDCK cells (subtype MDCKII) apical activation by
TGF-β has been reported [43]. Apical localization of
TGF-β receptor I was also reported in porcine vas defer-
ens epithelium [44]. In the kidney, Wang et al. had pro-
vided evidence for apical expression of TGF-β receptors
in a subset of rat cortical collecting duct cells, and
Figure 5 Preferential activation of Smad2/3 in polarized hPTEC of distal origin. Polarized hPTEC were treated with TGF-β for 1 h from the
apical or basolateral side. E-cadherin (red) and Smad2/3 (green) were detected by immunocytochemistry. Cells negative for E-cadherin represent
proximal cells. Upon activation with TGF-β, Smad2/3 was concentrated in the nuclei of proximal and distal cells, respectively. Arrows indicate
nuclear Smad2/3 in proximal E-cadherin negative cells and arrow heads indicate nuclear Smad2/3 in distal weakly E-cadherin positive cells. Scale
bar: 50 μm.
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showed in vitro reactivity of mouse proximal tubular
cells and renal inner medullary cell lines (mIMCD-3
cells) upon apical stimulation with TGF-β [45]. In our
experiments, TGF-β was clearly active when applied
from the apical side in a TGF-β receptor I-dependent
manner. Immunocytochemical analyses revealed that in
addition to proximal tubular cells only a subset of distal
cells reacted to apical TGF-β, characterized by low ex-
pression of E-cadherin. Further studies are necessary to
define the origin of these cells which obviously differ
from MDCK cells.
An additional level of complexity arises from the diver-
sity of TGF-β receptor signaling, which implies Smad
dependent and independent pathways (summarized in
[46]). Furthermore, TGF-β signaling depends on interac-
tions of its recptors with other membrane-bound pro-
teins including growth factor receptors and integrins
[47,48]. In our studies, apical TGF-β hardly activated the
canonical Smad pathway which was detected upon baso-
lateral application and may be essential for TGF-β secre-
tion as detected in MDCK cells. In MDCKII cells, apical
treatment with TGF-β increased transepithelial resist-
ance, which was prevented by inhibition of p38 and
ERK1/2 signaling [43]. In line with those studies, we
showed phosphorylation of ERK1/2 upon apical applica-
tion of TGF-β related to increased CTGF synthesis. A
role for active ERK1/2 in CTGF synthesis in non-
polarized epithelial cells was also described in epithelial
cells of the eye [49] and in proximal tubular cell lines
HKC-8 [21,22]. Activation N-Ras GTPase has been
implicated in ERK-mediated CTGF induction in HKC-8
cells [22]. Furthermore, evidence was provided for direct
phosphorylation of ShcA proteins by TGF-β receptor I
[50]. Whether these or other signaling pathways are also
involved in the apical induction of CTGF in primary
human tubular cells remains to be investigated.
Basolateral stimulation of tubular epithelial cells by
TGF-β rapidly activated Smad signaling in all distal tubu-
lar cells and also part of the proximal cells. By contrast,
only distinct cell populations stained positive for intra-
cellular CTGF at any given time point after TGF-β
stimulation. This may in part be due to the fact that
intracellular CTGF can only be detected when it
accumulates in the secretory pathway. However, more
likely it reflects the fact that activation of the Smad path-
way is not sufficient for CTGF synthesis and secretion.
For instance, induction of CTGF by TGF-β in epithelial
cells cultured in dishes was strongly dependent on cell
density, whereas Smad translocation was density-
independent [20]. The signaling pathways which regulate
density-dependent CTGF synthesis are not yet known
but may also modulate CTGF expression in polarized
cells.
Cellular uptake of CTGF has been observed in differ-
ent cell types, mesangial cells [51], fibroblasts [52], chon-
drocytes [53] or endothelial cells (Muehlich, Goppelt-
Struebe, unpublished), and was also shown in vivo in
proximal tubular cells in mice upon CTGF injection
[14]. Our experiments confirmed uptake of exogenous
CTGF in proximal cells. In addition, we observed CTGF
uptake in the subset of E-cadherin positive cells, which
also secreted CTGF upon stimulation with apical TGF-β
as discussed above.
It was interesting to note that upon stimulation with
TGF-β, CTGF was not exclusively secreted to the apical
side but also detectable at the basolateral side. Extrapo-
lating to the in vivo situation, this may imply that the
secreted CTGF is not lost in the urine but may be poten-
tially active as a paracrine mediator. This aspect is sup-
ported by in vivo studies showing a role for tubular
CTGF in the model system of remnant kidney disease in
TGF-β1 transgenic mice [54]. Activated epithelial cells
may thus contribute to the increased CTGF plasma
levels detected in chronic kidney disease also in humans
[1-3]. Furthermore, the strong apical secretion of CTGF
suggests that also in vivo, activated tubular cells may
have a share in urinary CTGF levels not only by uptake
of filtered CTGF but also by secretion. Whether or not
urinary CTGF has a functional role by acting on further
distal tubular cells, remains to be established. Thus far,
the biological effects of CTGF on distal tubular cells
have not yet been investigated.
Conclusions
In this study we provide evidence that non trans-
formed polarized human epithelial cells secrete the
(See figure on previous page.)
Figure 6 Accumulation of intracellular CTGF upon stimulation with basolateral TGF-β. A: hPTEC were polarized and then stimulated with
TGF-β for 1 h from the basolateral side. N-cadherin (green) and CTGF (red) were detected by immunocytochemistry. Control cells showed CTGF
expression only in clustered proximal tubular cells (arrow, upper panels). Treatment with TGF-β from the basolateral side activated CTGF primarily
in distal tubular cells (lower panels). Scale bar: 20 μm. B: Higher magnification of an experiment performed as in A with cells stimulated with TGF-
β from the basolateral side. E-cadherin (red) and CTGF (green) were detected by immunocytochemistry. Arrows indicate examples of positive cells.
Scale bar: 20 μm. C: Polarized hPTEC were treated with brefeldin A (10 μM) for 30 min and then were incubated with TGF-β from the apical side
for 2 h. E-cadherin (red) and CTGF (green) were detected by immunocytochemistry. Arrows indicate examples of CTGF positive proximal cells,
which were negative for E-cadherin; arrow heads indicate examples of CTGF positive distal cells, which weakly express E-cadherin. Scale bar:
20 μm.
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pro-fibrotic protein CTGF in a cell-type and stimulus-
specific manner. Furthermore, CTGF secretion was dis-
tinguishable from other secreted proteins indicative of
specific molecular mechanisms regulating vectorial se-
cretion. Most interestingly, CTGF was not only
secreted but also taken up by proximal tubular cells.
Approximating the in vivo situation, our model system
is thus suitable for further investigation of secretion




DMEM/Ham’s F12 medium was purchased from Bio-
chrom AG (Berlin, Germany), DMEM medium and
Hank’s BSS from PAA Laboratories (Coelbe, Germany),
insulin-transferrin-selenium supplement from Gibco
(Karlsruhe, Germany), fetal calf serum (FCS) from PAN
Biotech (Aidenbach, Germany), triiodothyronine from
Fluka (Buchs, Switzerland), hydrocortisone from Sigma
(Munich, Germany), epidermal growth factor from
Figure 7 Role for MAP kinases in apical TGF-β-mediated secretion of CTGF. A: Polarized hPTEC were incubated with inhibitors (U0: U0106,
1 μM; SB203: SB203580, 1 μM; Y27: Y27632, 10 μM; SB43: SB431542: 10 μM) for 30 min and then stimulated with TGF-β from the apical side for
6 h. CTGF secretion was detected in the apical compartment. The graph summarizes means +/− SD of 3 independent experiments. Secretion of
CTGF in TGF-β-stimulated cells was set to 1 in each experiment. ** p < 0.01, * p < 0.05 compared to TGF-β-stimulated cells, Dunnet’s multiple
comparison test. B: Polarized hPTECs were stimulated in duplicate with TGF-β for 15 and 60 min from the apical side. Protein was isolated from
polarized cells. ERK1/2 and phospho-ERK1/2 were detected by Western blotting.
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PeproTech (Hamburg, Germany), TGF-β1 from tebu-
bio (Offenbach, Germany), lysophosphatidic acid (LPA)
(Sigma-Aldrich, Munich, Germany); Rho kinase inhibi-
tor Y27632, TGF-β RI Kinase Inhibitor VI, SB431542,
MEK kinase inhibitor U0126, p38 kinase inhibitor and
brefeldin A were obtained from Calbiochem, Munich,
Germany.
Cell culture
Human primary tubular epithelial cells (hPTEC) were iso-
lated from renal cortical tissues collected from healthy
parts of tumor-nephrectomies essentially as described pre-
viously [18]. Isolation of human cells was approved by the
local ethics committee and written consent was obtained
from all donors. In brief, after transport in Hank’s BSS,
Figure 8 Uptake of extracellular CTGF from the apical side. A: Polarized hPTEC were treated with recombinant CTGF (10 ng/ml) for 15 min
from the apical side. Cells were stained for E-cadherin (red) and CTGF (green). CTGF immunoreactivity was detected primarily in E-cadherin
negative, proximal cells. Scale bar: 20 μm. B: Cells were treated as in A. N-cadherin positive cells (red) are shown at higher magnification. CTGF
(green) is detectable in vesicular structures. Scale bar: 20 μm. C: Cells were treated as in A. Cells weakly positive for E-cadherin (red) showed CTGF
(green) immunoreactivity, whereas distal cells with strong E-cadherin cell-cell contacts were negative. Arrows indicate cells positive for CTGF. Scale
bar: 20 μm.
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cortex tissue was cut into 1 mm3 pieces and digested with
collagenase type II (Gibco, Karlsruhe, Germany) and DNase
I grade II (Roche Diagnostics, Mannheim, Germany) for
60 min. Next, cell suspension was sieved through 100 μm
and 70 μm meshes. After a washing step with HBSS, cells
were seeded in epithelial cell selective medium (DMEM/
Ham’s F12 medium containing 2 mML-glutamine,
100 U/ml penicillin, 100 μg/ml streptomycin, insulin-
transferrin-selenium supplement, 10 ng/ml epidermal
growth factor, 36 ng/ml hydrocortisone and 4 pg/ml
triiodothyronine) in the presence of 0.5% FCS. After
1–2 days, medium was replaced by FCS-free medium.
Cells were subcultured by application of trypsin. For
experiments, hPTEC were seeded in medium con-
taining 2.5% FCS to facilitate cell attachment, and
medium was replaced after 24 h to FCS-free epithe-
lial cell selective medium. Bright field pictures were
recorded by Olympus CK40 microscope (Olympus,
Hamburg, Germany) using Leica DC Viewer software
(Leica, Herbrugg, Switzerland).
About five days after isolation at passage one cells were
routinely analyzed for the content of proximal and distal
cell by staining for N- and E-cadherin, respectively. The
ratio of distal and proximal cells varied with most prep-
aration containing a higher percentage of distal cells
(about 70%).
Polarized tubular epithelial cells were obtained by cul-
turing primary epithelial cells for 8 days on permeable
transwell inserts (Millicell PCF, Millipore, Schwalbach,
Germany).
Transepithelial electrical resistance (TEER)
Transepithelial electrical resistance was measured using
a commercially available epithelial vpltohmeter and a set
of so-called chopstick electrodes (EVOM, World Preci-
sion Instruments, Berlin, Germany). All measurements
were corrected for resistance of culture medium and
empty inserts.
Western blot analysis
Cell culture supernatants were precipitated with ethanol.
Western blot analyses were performed essentially as
described before [20] using the following antibodies:
CTGF (SC-14939, Santa Cruz), phospho-ERK 1/2 and
ERK 1/2 (Cell Signaling), and fibronectin HNF7.1 devel-
oped by R.J Klebe obtained from the Developmental Stud-
ies Hybridoma Bank developed under the auspices of the
NICHD and maintained by The University of Iowa, De-
partment of Biology, Iowa City, IA 52242. The immunor-
eactive bands were quantified using the luminescent image
analyzer (LAS-1000 Image Analyzer, Fujifilm, Berlin,
Germany) and AIDA 4.15 image analyzer software (Raytest,
Berlin, Germany).
Real time RT-PCR
RNA of cells cultured in inserts was isolated and ana-
lyzed as described previously [20].
Immunocytochemistry
Cells were fixed with paraformaldehyde (3.5% in PBS) for
10 min and afterwards permeabilized by 0.5% Triton X-
100 in PBS for 10 min. After washing three times with
PBS, cells were blocked in 1% BSA in PBS. Antibodies
used for Immunocytochemistry: E-cadherin (Abcam), N-
cadherin (Santa Cruz), CTGF (Santa Cruz), acetylated
tubulin (Sigma), Smad2/3 (Cell Signaling). Alexa Fluor
488- or 555-conjugated secondary antibodies were from
Invitrogen.
After mounting, slides were viewed using a Nikon
Eclipse 80i fluorescent microscope and digital images
recorded by Visitron Systems 7.4 Slider camera (Diag-
nostic Instruments, Sterling Heights, MI, USA) using
Spot Advanced software (Diagnostic Instruments). Three
dimensional images were evaluated by epifluorescence mi-
croscopy including Apotome technique (Zeiss, Göttingen,
Germany).
Recombinant CTGF
A full length human CTGF cDNA, kindly provided by
M. Bauer, Med. Clinic 1, Erlangen, was expressed in
HEK293 cells. His-tagged CTGF was purified from cell
culture supernatants using Ni-columns (Protino, Machery
and Nagel, Düren, Germany). Purity of the protein was
shown by silver staining of SDS polyacrylamide gels and
estimated to be over 90%.
Statistical analysis
To compare multiple conditions, statistical significance
was calculated by one-way ANOVA with Dunnett’s post
hoc test using GraphPad software. A value of P < 0.05
was considered to indicate significant differences.
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